Cargando…
Ketamine and Calcium Signaling—A Crosstalk for Neuronal Physiology and Pathology
Ketamine is a non-competitive antagonist of NMDA (N-methyl-D-aspartate) receptor, which has been in clinical practice for over a half century. Despite recent data suggesting its harmful side effects, such as neuronal loss, synapse dysfunction or disturbed neural network formation, the drug is still...
Autores principales: | Lisek, Malwina, Zylinska, Ludmila, Boczek, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665128/ https://www.ncbi.nlm.nih.gov/pubmed/33182497 http://dx.doi.org/10.3390/ijms21218410 |
Ejemplares similares
-
Vitamin C Modes of Action in Calcium-Involved Signaling in the Brain
por: Zylinska, Ludmila, et al.
Publicado: (2023) -
Crosstalk among Calcium ATPases: PMCA, SERCA and SPCA in Mental Diseases
por: Boczek, Tomasz, et al.
Publicado: (2021) -
Regional brain dysregulation of Ca(2+)-handling systems in ketamine-induced rat model of experimental psychosis
por: Lisek, Malwina, et al.
Publicado: (2015) -
Erratum to: Regional brain dysregulation of Ca2+-handling systems in ketamine-induced rat model of experimental psychosis
por: Lisek, Malwina, et al.
Publicado: (2016) -
The Role of MEF2 Transcription Factor Family in Neuronal Survival and Degeneration
por: Lisek, Malwina, et al.
Publicado: (2023)